SHWTHE SHERWIN-WILLIAMS COMPANYLarge cap · $82.37B · FY ending 2025-12-31
$333.99+0.59% · 2026-07-10 · EOD
57/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality80
wide moat · ROIC 24%Value51
P/E 32.6 · 50% of 12-mo rangeMomentum48
death · price above 200-daySmart Money47
quiet · 0 funds · 0P/1S insidersMixed trendDeath crossAbove 200-day
vs S&P 500-8.7%
6-mo excess Trailing performance1M +7.5%
3M -0.5%
6M +0.8%
YTD +1.9%
1Y -5.0%
P/E vs its last 12 months (our price history): 28.6 low → 36.6 high
Current price sits at the 50th percentile of that window — mid-range. We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Wide moat — ROIC 24%
Piotroski F6/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 23%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio30.7%
comfortable Shareholder yield1.0%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Quiet0P / 1S insiders · 0 funds hold · 0 Congress buys
Recent insidersYoung Bryan J · SVP - Corp Strategy & Devel.SELL$915,913
CongressMaria Elvira SalazarSELL2026-05-12
Chealth · 69/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.